NOVUM PHARMA

Lobbying Spend

—

Filings

Firms Hired

Active Period

2018–2020

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2020	—	1	1
2019	—	4	1
2018	—	4	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
BUCHANAN INGERSOLL & ROONEY PC	—	9

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
Food & Drug Administration (FDA)	6
HOUSE OF REPRESENTATIVES	6
SENATE	6

Most frequently reported lobbying issues

Issue Code	Description	Reports
Pharmacy	Pharmacy	7
Health Issues	Health Issues	7

NOVUM PHARMA — Lobbying Disclosure | Poliscope